共 50 条
- [42] Comparison of the efficacy and safety of olokizumab at different dosages in patients with active rheumatoid arthritis: a network meta-analysis of randomized controlled trials ZEITSCHRIFT FUR RHEUMATOLOGIE, 2024, 83 (SUPPL 1): : 107 - 114
- [43] Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis: a network meta-analysis of randomized controlled trials ZEITSCHRIFT FUR RHEUMATOLOGIE, 2024, 83 (SUPPL 1): : 97 - 106
- [46] Comparison of the efficacy and safety of tofacitinib and baricitinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (06): : 559 - 567
- [48] The Risk of Adverse Effects of TNF-α Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis FRONTIERS IN IMMUNOLOGY, 2022, 13
- [49] Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (11) : 1103 - 1111